According to The Deal report Verisk Analytics has hired Morgan Stanley to sell its healthcare analytics unit. Bankers think the business could sell for 10x-12x EBITDA, which (based on expected EBITDA of $90M) would spell a valuation of $900M-$1.08B.

Verisk is not the only large company considering divestitures of healthcare IT units. In early September, 3M  (MMM – Get Report) announced that it was exploring strategic alternatives for its global Health Information Systems Businesses, including spinning off, selling, or retaining and investing in the business.

Why the sudden interest of getting out of the Health Care Business?  Stay tuned.